Obese/overweight PCOS with IR (especially metformin-intolerant) B
Over a median 7.5-year follow-up, 298 participants developed obesity-related cancers, with postmenopausal breast cancer (26%), colorectal cancer (16%), and endometrial cancer (15%) most prevalent
After 72 weeks, participants taking 7.2mg lost an average of 18.7% of their starting body weight, compared with 3.9% in the placebo group
If you are a vegetarian or vegan, discuss dietary sources or supplements of B12 with your Practitioner Follow-Up: Depending on your specific condition and the reason for the injection, your Practitioner will determine the frequency of future injections.
Your medical history, health history and treatment priorities should guide this decision in consultation with your healthcare provider